Indivior Pharmaceuticals Inc
INDV
Classifica tra le azioni
#4006
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Prezzo delle azioni
$32.56
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$4.06B
Variazione (1 giorno)
-3.15%
Variazione (1 anno)
33.01%
Paese
US
Scambia Indivior Pharmaceuticals Inc (INDV)
Categoria
Healthcare
EPS per Indivior Pharmaceuticals Inc (INDV)
EPS al June 2026 TTM: $2.84
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Indivior Pharmaceuticals Inc, l’EPS attuale della società (TTM) è $2.84. Alla fine del 2023, la società aveva un EPS di $0.01 un aumento rispetto a rispetto a quello del 2022, che era di $-0.37.
Storico EPS per Indivior Pharmaceuticals Inc da 2016 a 2026
EPS alla fine di ogni anno
| Anno | EPS | Cambia |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS per aziende simili o concorrenti
| Azienda | EPS | Differenza di EPS | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
